Comments

Protara Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Protara Therapeutics (TARA) operate in?

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TARANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.31

-0.42-8.88%

Pre-Market: 6:11 PM EDT

Protara Therapeutics (TARA) Forecast

News Earnings Protara Therapeutics (TARA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Protara Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TARA | Benzinga

Explore Protara Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TARA.

Open	-
Close	-
Volume / Avg.	61.00 / 304.87K
Day Range	- - -
52 Wk Range	1.60 - 10.48
Market Cap	$158.47M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	9.38%
Days to Cover	8.29

Recent News

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.

Chris Katje

Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Crude Oil Edges Lower; US Initial Jobless Claims Increase

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	61.00 / 304.87K
Day Range	- - -
52 Wk Range	1.60 - 10.48
Market Cap	$158.47M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	9.38%
Days to Cover	8.29

About Protara Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for peop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Protara Therapeutics (TARA) stock?

You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.

View our list of the best stock brokerages

Who are Protara Therapeutics (TARA) competitors?

Other companies in Protara Therapeutics’s space includes: Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).

What is the forecast, or price target, for Protara Therapeutics (TARA) stock?

Protara Therapeutics has a consensus price target of $22.40.

What is the current price for Protara Therapeutics (TARA)?

The stock price for Protara Therapeutics (NASDAQ: TARA) is $4.31 last updated March 25, 2025 at 6:11 PM EDT.

Does Protara Therapeutics (TARA) pay a dividend?

There are no upcoming dividends for Protara Therapeutics.

When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?

Protara Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Protara Therapeutics (TARA) going to split?

There is no upcoming split for Protara Therapeutics.

What sector and industry does Protara Therapeutics (TARA) operate in?

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.